Janus Henderson Group PLC Purchases 95,445 Shares of CorVel Co. (NASDAQ:CRVL)

Janus Henderson Group PLC boosted its position in shares of CorVel Co. (NASDAQ:CRVL) by 230.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 136,908 shares of the business services provider’s stock after acquiring an additional 95,445 shares during the quarter. Janus Henderson Group PLC owned 0.27% of CorVel worth $15,233,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CRVL. Barclays PLC increased its holdings in shares of CorVel by 380.8% in the third quarter. Barclays PLC now owns 15,977 shares of the business services provider’s stock valued at $5,223,000 after purchasing an additional 12,654 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of CorVel by 9.9% in the third quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider’s stock valued at $614,000 after purchasing an additional 173 shares during the last quarter. Ellsworth Advisors LLC increased its holdings in shares of CorVel by 210.6% in the fourth quarter. Ellsworth Advisors LLC now owns 7,269 shares of the business services provider’s stock valued at $809,000 after purchasing an additional 4,929 shares during the last quarter. Ballentine Partners LLC boosted its position in shares of CorVel by 211.0% in the fourth quarter. Ballentine Partners LLC now owns 2,429 shares of the business services provider’s stock valued at $270,000 after acquiring an additional 1,648 shares during the period. Finally, Nisa Investment Advisors LLC boosted its position in shares of CorVel by 217.1% in the fourth quarter. Nisa Investment Advisors LLC now owns 555 shares of the business services provider’s stock valued at $62,000 after acquiring an additional 380 shares during the period. 51.36% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Alan Hoops sold 10,200 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the sale, the director now owns 118,213 shares of the company’s stock, valued at $13,758,811.07. This represents a 7.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jeffrey J. Michael sold 16,523 shares of the company’s stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the sale, the director now directly owns 551,787 shares of the company’s stock, valued at $64,553,561.13. This represents a 2.91% decrease in their position. The disclosure for this sale can be found here. Insiders sold 37,200 shares of company stock valued at $4,340,250 over the last quarter. 47.57% of the stock is owned by company insiders.

CorVel Stock Performance

Shares of CorVel stock opened at $113.71 on Friday. The firm has a 50-day moving average of $111.20 and a 200-day moving average of $116.35. The stock has a market cap of $5.84 billion, a PE ratio of 66.89 and a beta of 1.10. CorVel Co. has a 52-week low of $76.53 and a 52-week high of $128.61.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of CorVel from a “hold” rating to a “buy” rating in a research report on Friday, April 18th.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.